Skip to main content
Log in

Pregabalin cost effective for chronic neuropathic low back pain

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. Japanese yen

Reference

  • Igarashi A, et al. Cost-effectiveness analysis of pregabalin for treatment of chronic low back pain in patients with accompanying lower limb pain (neuropathic component) in Japan. ClinicoEconomics and Outcomes Research 7: 505-520, 7 Oct 2015. Available from: URL: http://dx.doi.org/10.2147/CEOR.S89833

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pregabalin cost effective for chronic neuropathic low back pain. PharmacoEcon Outcomes News 739, 23 (2015). https://doi.org/10.1007/s40274-015-2541-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2541-8

Navigation